FDA Inspection
Auro PR IncAuro PR Inc – FDA Inspection, Mar 15, 2018
Record Details
This FDA Inspection record concerns Auro PR Inc, with an inspection on March 15, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- jose a lopez rubet (Investigator)
- Jose R Flores-Veguilla (Issuing Officer)
- Marian E. Ramirez (Company Rep)
- Vilmary Negron Rodriguez (Issuing Officer)
View Company Profile
ID · f582c458-527a-4d65-8563-b81390b480d3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1044364
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 211.82(a)Examination on receipt, before acceptance
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.67(b)(3)Cleaning SOPs/instructions
- 21 CFR 211.160(b)(4)Calibration - at intervals, written program, remedial action
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Auro PR Inc
8| Date | Classification | Office | Project area |
|---|---|---|---|
| May 31, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 24, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 22, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 24, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 7, 2012 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Auro PR Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.